Connection
Kathryn Hassell to Anticoagulants
This is a "connection" page, showing publications Kathryn Hassell has written about Anticoagulants.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.251 |
|
|
|
-
Schofield JR, Hassell K. Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome. J Clin Pharm Ther. 2018 Feb; 43(1):104-106.
Score: 0.396
-
Hassell K. Heparin-induced thrombocytopenia: diagnosis and management. Thromb Res. 2008; 123 Suppl 1:S16-21.
Score: 0.216
-
Kiser TH, Burch JC, Klem PM, Hassell KL. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2008 Sep; 28(9):1115-24.
Score: 0.215
-
Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest. 2005 Feb; 127(2 Suppl):1S-8S.
Score: 0.168
-
Farrar JE, Trujillo TC, Mueller SW, Beltran L, Nguyen C, Hassell K, Kiser TH. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19. J Thromb Thrombolysis. 2022 Feb; 53(2):446-453.
Score: 0.132
-
Anderson M, Hassell KL, Trujillo TC, Wolfe B. When patients on target-specific oral anticoagulants need surgery. Cleve Clin J Med. 2014 Oct; 81(10):629-39.
Score: 0.082
-
Hassell KL. Altered hemostasis in pulmonary hypertension. Blood Coagul Fibrinolysis. 1998 Mar; 9(2):107-17.
Score: 0.026
-
Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010 Nov; 30(11):1117-26.
Score: 0.016